The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

An artificial intelligence model has created a new protein that researchers say would have taken 500 million years to evolve in nature — if nature were capable of producing such a thing.

Copyright 2025 The Associated Press. All Rights Reserved. This undated photo shows Coca-Cola Orange Cream. (Coca-Cola via AP) This undated photo shows Coca-Cola ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

On Monday, the soda giant announced that it's releasing Coca-Cola Orange Cream. According to the brand, the new drink is a "delicious taste of Coca-Cola infused with refreshing orange and smooth ...

If you’re not familiar with the term, orange peel refers to a textured, dimpled finish on a car’s paint that looks like the surface of an orange. It’s usually caused by improper spraying or ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

Got a tip? Send it to The Daily Beast here. ADVERTISEMENT ADVERTISEMENT ...

fluorescent protein. Prior research has shown that synthesizing proteins can provide unique insights into the structure and function of natural proteins. To date, most such proteins are copies of ...